Moreover, CD23 (c) was strongly and diffusely expressed, particularly in areas with dense tumor cell infiltration, further supporting the diagnosis, as CD23 is a key differentiating marker from other B-cell lymphomas. This evidence concerns the gene FCER2 and neoplasm.